Mayne Pharma | MYX - Debt

Stock Price
2.40
Daily Change
0.13 5.73%
Monthly
-2.04%
Yearly
-66.81%
Q2 Forecast
2.23

Mayne Pharma reported AUD38.82M in Debt for its fiscal semester ending in June of 2024.





Debt Change Date
Ansell USD 805.6M 51.6M Jun/2025
Avita Medical AUD 46.05M 1.46M Dec/2025
Cochlear AUD 235.7M 10.9M Jun/2025
CSL USD 11.96B 219M Dec/2024
Healius AUD 1.4B 199.1M Dec/2024
Integral Diagnostics AUD 357.8M 3.7M Jun/2024
Medical Developments International AUD 1.99M 152K Jun/2025
Nanosonics AUD 7.69M 1.49M Jun/2025
Polynovo AUD 15.38M 49K Jun/2024
Ramsay Health Care AUD 12.12B 864.4M Jun/2025
ResMed USD 846.35M 5.46M Sep/2025
Sigma Healthcare AUD 137.64M 1.01M Jul/2024
Sonic Healthcare AUD 4.8B 282.9M Dec/2024
Telix Pharmaceuticals AUD 418.25M 163.2M Jun/2025